Impact of Results of TTF-1 Immunostaining on Efficacy of Platinum-Doublet Chemotherapy in Japanese Patients with Nonsquamous Non-Small-Cell Lung Cancer

Background: Pemetrexed is a key drug in chemotherapy for nonsquamous non-small-cell lung cancer (nonsq NSCLC). Several studies have reported thyroid transcription factor-1 (TTF-1) as a biomarker of the efficacy in chemotherapy regimens, including pemetrexed in non-Asian people. Objective: We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Akira, Inoue, Hiroyuki, Ikeuchi, Nobumitsu, Igata, Fumiyasu, Aoyama, Takashi, Hamasaki, Makoto, Arima, Hisatomi, Fujita, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821382/
https://www.ncbi.nlm.nih.gov/pubmed/36614938
http://dx.doi.org/10.3390/jcm12010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821382/
https://www.ncbi.nlm.nih.gov/pubmed/36614938
http://dx.doi.org/10.3390/jcm12010137

Ejemplares similares